#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Ureteric cancer Transitional cell cancer of the renal pelvis and ureter Pulmonary alveolar haemorrhage Uveitis Diffuse large B-cell lymphoma recurrent Chronic graft versus host disease in liver Cold type haemolytic anaemia Alveolar proteinosis Haemophilia Leukocyte adhesion deficiency Ovarian epithelial cancer Chronic lymphocytic leukaemia Primary mediastinal large B-cell lymphoma Chronic graft versus host disease in skin KBG syndrome More trials…

    Learn about Rare Diseases

    Skin angiosarcoma – Life with Disease Inclusion body myositis – Treatment Marfan’s syndrome Lymphangioma – Basic Information Crigler-Najjar syndrome – Life with Disease Lymphatic malformation – Diagnostics Waldenstrom’s macroglobulinaemia recurrent – Treatment Synovial sarcoma metastatic – Basic Information Von Willebrand’s disease – Life with Disease Rhabdomyosarcoma – Basic Information More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Sonelokimab GRNA-001 Gad20-209-Fsp-A4 Azithromycin Dihydrate Nystatin Forimtamig Oregovomab CYCLIZINE HYDROCHLORIDE NADOFARAGENE FIRADENOVEC Lenacapavir Sodium Felis Domesticus (555) Telisotuzumab Vedotin L-Histidine Hydrochloride Glyceryl Trinitrate Vidutolimod Olopatadine Hydrochloride Cenerimod Mometasone Furoate Ph. Eur. Lutropin Alfa Oxytocin Synthetic More therapies…

    Learn about Your Condition

    Benign neoplasm of ureter Lung cancer metastatic Metastases to biliary tract Ectopic pregnancy Post-traumatic stress disorder Latent tuberculosis Adrenal insufficiency Diabetic foot Multiple system atrophy Haematological malignancy Caesarean section Pulmonary embolism Haemoptysis Gestational diabetes B-cell lymphoma refractory More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Uncategorized

  • Study on Antibiotic Treatments for Kidney Infection in Children: Comparing Cefixime, Ceftriaxone, and Amikacin for Ages 1 Month to 3 Years

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Pyelonephritis acute
    Investigated Drugs:
    • Cefixime Trihydrate
    • Amikacin Sulfate
    • Tolu Balsam
    France

  • Study Comparing Rezvilutamide and Bicalutamide with Hormone Therapy for Patients with Advanced Prostate Cancer

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Prostate cancer
    Investigated Drugs:
    • Rezvilutamide
    • Bicalutamide
    • Goserelin
    Bulgaria Czechia Poland

  • Study on Short vs. Standard Amoxicillin Treatment for Adults with Lower Limb Erysipelas

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Pyoderma
    Investigated Drugs:
    • Amoxicillin Sodium
    France

  • Study on the Effects of Sabirnetug for Patients with Early Alzheimer’s Disease

    Not yet recruiting

    2 1 1
    Investigated Drugs:
    • Sabirnetug
    • Florbetapir (18F)
    • Florbetaben (18F)
    France Germany Spain

  • Study of GBT021601 for Adults and Children with Sickle Cell Disease

    Not yet recruiting

    4 1
    Investigated Drugs:
    • (S)-2-Hydroxy-6-((4-(2-(2-Hydroxyethyl)Nicotinoyl)Morpholin-3-Yl)Methoxy)Benzaldehyde
    France Germany Greece

  • Study on the Safety and Effectiveness of Lutikizumab and Adalimumab for Adults with Moderate to Severe Ulcerative Colitis

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    • Colitis ulcerative
    Investigated Drugs:
    • Adalimumab
    • Lutikizumab
    Austria Belgium Bulgaria Croatia Estonia France +12
Previous Page
1 … 848 849 850 851 852 … 1,674
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!